SU473361A3 - Способ получени 3-(2"3"-дидезоксигликозидов)карденолида - Google Patents

Способ получени 3-(2"3"-дидезоксигликозидов)карденолида

Info

Publication number
SU473361A3
SU473361A3 SU1691889A SU1691889A SU473361A3 SU 473361 A3 SU473361 A3 SU 473361A3 SU 1691889 A SU1691889 A SU 1691889A SU 1691889 A SU1691889 A SU 1691889A SU 473361 A3 SU473361 A3 SU 473361A3
Authority
SU
USSR - Soviet Union
Prior art keywords
dideoxy
ether
solution
spectrum
water
Prior art date
Application number
SU1691889A
Other languages
English (en)
Russian (ru)
Inventor
Штахе Ульрих
Фрич Вернер
Хеде Вернер
Радшайт Курт
Линднер Эрнст
Original Assignee
Хехст Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст Аг (Фирма) filed Critical Хехст Аг (Фирма)
Application granted granted Critical
Publication of SU473361A3 publication Critical patent/SU473361A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005Glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SU1691889A 1969-08-29 1970-08-28 Способ получени 3-(2"3"-дидезоксигликозидов)карденолида SU473361A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1943901A DE1943901C3 (de) 1969-08-29 1969-08-29 Cardenolid-3-[2', 3' - didesoxyglykoside] und Verfahren zu ihrer Herstellung, sowie Verwendung dieser Verbindungen zur Bekämpfung von Herzkrankheiten

Publications (1)

Publication Number Publication Date
SU473361A3 true SU473361A3 (ru) 1975-06-05

Family

ID=5744085

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1691889A SU473361A3 (ru) 1969-08-29 1970-08-28 Способ получени 3-(2"3"-дидезоксигликозидов)карденолида

Country Status (7)

Country Link
AT (1) AT320868B (de)
BR (1) BR6915188D0 (de)
CS (1) CS151563B2 (de)
DE (1) DE1943901C3 (de)
EG (1) EG10305A (de)
SU (1) SU473361A3 (de)
ZA (1) ZA705564B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256912C2 (de) * 1972-11-20 1984-04-05 Hoechst Ag, 6230 Frankfurt Digoxigenin-3-[2',3'-didesoxy-glykoside], Verfahren zu ihrer Herstellung und deren Verwendung

Also Published As

Publication number Publication date
DE1943901C3 (de) 1978-11-02
DE1943901B2 (de) 1978-03-09
CS151563B2 (de) 1973-10-19
AT320868B (de) 1975-03-10
EG10305A (en) 1976-03-31
ZA705564B (en) 1971-04-28
DE1943901A1 (de) 1971-05-19
BR6915188D0 (pt) 1973-02-13

Similar Documents

Publication Publication Date Title
US3296255A (en) 2-cyano steroids
NO128152B (de)
NO140977B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
SU473361A3 (ru) Способ получени 3-(2"3"-дидезоксигликозидов)карденолида
US4325879A (en) Amino-14 steroid derivatives and process for preparation of the same
US3478062A (en) Certain tetrahydroindane derivatives
US2656349A (en) 14,15-oxides of the cyclopentanopolyhydrophenanthrene and polyhydrochrysene series
CH507224A (de) Verfahren zur Herstellung von 7(a und B)-Methyl-3B-hydroxy-5-androstenen, 2a,7(a und B)-Dimethyl-3B-hydroxy-5-androstenen sowie deren 19-Nor-Derivaten
Smith 173. Lactones of glucosaccharic acid. Part III. Mono-and di-lactones
DE1793618C3 (de) 07.03.63 USA 263441 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden der Androstanreihe
US3312717A (en) 3-oxygenated-13beta-alkyl-16-oxagona-1, 3, 5(10)-trien-17-ones, d-homo compounds corresponding, derivatives thereof, and intermediates thereto
US2833792A (en) 1, 3, 17-trioxygenated androstane derivatives
EP0440752A1 (de) Verfahren zur herstellung von 3-desoxy-4-en-steroiden.
US3313703A (en) 19-nor-deta4, 9, 11-pregnatriene-3, 20-dione, process and intermediates
US3067218A (en) 2alpha, 17alpha-dimethyl derivatives of the androstane series
US2745829A (en) Preparation of 3-hydroxy-11-ketocholanic acid, derivatives and analogs thereof, and intermediates in said preparation
US2880213A (en) 6alpha-alkyl-4, 16-pregnadiene-3, 20-diones
US3377342A (en) 2', 2'-bistrifluoromethyloxetano(3', 4'; 16alpha, 17alpha)derivatives of 4-pregneno [3, 2-c]pyrazoles and 4, 6-pregnadieno [3, 2-c]pyrazoles
US2636043A (en) Method of preparing 16-ketosteroids
US3122573A (en) Process for the production of 16alpha-methyl-17alpha-hydroxy-pregnane-20-ones and intermediates therefor
SU432716A3 (ru) Способ получения 18-метиленстероидов ряда прегнана
US3102892A (en) Cyclopentanophenanthrene compounds and process
US4096142A (en) 14,19-Dioxygenated steroid compounds and their 14-dehydro analogs and process for the preparation thereof
US3232967A (en) 16,21-dihydroxy-4,17(20)-pregnadiene-3,11-dione and process for production thereof
AT238888B (de) Verfahren zur Herstellung von neuen, in 16-Stellung durch eine Methylgruppe substituierten 3α-Hydroxy-11,20-dioxo-21-pregnanglyoxylsäuren